Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: Involvement of dopaminergic and opioidergic mechanisms

Behavioural Brain Research

Volumn 181, Issue 1, 2007, Pages 35-41

  Zarrindast, Mohammad Reza ^a,b,c   Ebrahimi Ghiri, Mohaddeseh ^d   Rostami, Parvin ^d   Rezayof, Ameneh ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d KHARAZMI UNIVERSITY   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Conditioned place preference; Morphine; Naloxone; Rat; SCH 23390; Sulpiride; Ventral pallidum

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR; MORPHINE; NALOXONE; OPIATE RECEPTOR; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; AVERSION; BEHAVIOR CHANGE; CONDITIONED REFLEX; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG REEXPOSURE; GLOBUS PALLIDUS; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; GLOBUS PALLIDUS; MALE; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, WISTAR; SULPIRIDE;

EID: 34248563483     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.03.019     Document Type: Article

References (61)

1. Austin M.C., and Kalivas P.W. Enkephalinergic and GABAergic modulation of motor activity in the ventral pallidum. J Pharmacol Exp Ther 252 (1990) 1370-1377
2. Beckstead R.M. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience 27 (1988) 851-863
3. Belzung C., and Barreau S. Diffrences in drug-induced place conditioning between BALB/c and C57Bl/6 mice. Pharmacol Biochem Behav 65 (2000) 419-423
4. Boyson S.J., and Adams C.E. D1 and D2 dopamine receptors in perinatal and adult basal ganglia. Pediatr Res 41 (1997) 822-831
5. Carr G.D., and White N.M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci 33 (1983) 2551-2557
6. Chrobak J.J., and Napier T.C. Opioid and GABA modulation of accumbens-evoked ventral pallidal activity. J Neural Transm Gen Sect 93 (1993) 123-143
7. De Fonseca F.R., Rubio P., Martin-Calderon J.L., Caine S.B., Koob G.F., and Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 274 (1995) 47-55
8. Fuller T.A., Russchen F.T., and Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J Comp Neurol 258 (1987) 317-338
9. Gaiardi M., Bartoletti M., Bacchi A., Gubellini C., Costa M., and Babbini M. Role of repeated exposure to morphine in determining its affective properties: place and taste conditioning studies in rats. Psychopharmacology 103 (1991) 183-186
10. Gong W., Neill D., and Justice Jr. J.B. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res 707 (1996) 64-74
11. Gong W., Justice Jr. J.B., and Neill D. Dissociation of locomotor and conditioned place preference responses following manipulation of GABA-A and AMPA receptors in ventral pallidum. Prog Neuropsychopharmacol Biol Psychiatry 21 (1997) 839-852
12. Gong W., Neill D.B., Lynn M., and Justice Jr. J.B. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93 (1999) 1349-1358
13. Hiroi N., and White N.M. The ventral pallidum area is involved in the acquisition but not expression of the amphetamine conditioned place preference. Neurosci Lett 156 (1993) 9-12
14. Hoffman D.C., West T.E., and Wise R.A. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats. Brain Res 7 550 (1991) 205-212
15. Jeziorski M., and White F.J. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 275 (1995) 235-244
16. Johnson P.I., and Napier T.C. Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine. Synapse 38 (2000) 61-70
17. Johnson P.I., Stellar J.R., and Paul A.D. Regional reward differences within the ventral pallidum are revealed by microinjections of a mu opiate receptor agonist. Neuropharmacology 32 (1993) 1305-1314
18. Kalivas P.W., and Duffy P. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J Pharmacol Exp Ther 241 (1987) 204-212
19. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
20. Kalivas P.W., and Nakamura M. Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9 (1999) 223-227
21. Klitenick M.A., Deutch A.Y., Churchill L., and Kalivas P.W. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 50 (1992) 371-386
22. Kuribara H. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 275 (1995) 251-258
23. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berlin) 98 (1989) 357-362
24. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci 11 (1988) 308-314
25. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18 (1995) 22-29
26. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 8 (1995) 283-305
27. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., Navarro M., and Minarro J. Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 15 (2004) 1373-1377
28. Manzanedo C., Aguilar M.A., Rodriguez-Arias M., and Minarro J. Sensitization to the rewarding effects of morphine depends on dopamine. Neuroreport 16 (2005) 201-205
29. Maslowski-Cobuzzi R.J., and Napier T.C. Activation of dopaminergic neurons modulates ventral pallidal responses evoked by amygdala stimulation. Neuroscience 62 (1994) 1103-1119
30. McDaid J., Graham M.P., and Napier T.C. Methamphetamine-induced sensitization differentially alters pCREB and {Delta}FosB throughout the limbic circuit of the mammalian brain. Mol Pharmacol 70 (2006) 2064-2074
31. Mitrovic I., and Napier T.C. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum. J Pharmacol Exp Ther 272 (1995) 1260-1270
32. Napier T.C., and Potter P.E. Dopamine in the rat ventral pallidum/substantia innominata: biochemical and electrophysiological studies. Neuropharmacology 28 (1989) 757-760
33. Napier T.C. Dopamine receptors in the ventral pallidum regulate circling induced by opioids injected into the ventral pallidum. Neuropharmacology 31 (1992) 1127-1136
34. Olive M.F., Anton B., Micevych P., Evans C.J., and Maidment N.T. Presynaptic versus postsynaptic localization of mu and delta opioid receptors in dorsal and ventral striatopallidal pathways. J Neurosci 17 (1997) 7471-7479
35. Olmstead M.C., and Franklin K.B. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav Neurosci 111 (1997) 1313-1323
36. Panagis G., Kastellakis A., and Spyraki C. Involvement of the ventral tegmental area opiate receptors in self-stimulation elicited from the ventral pallidum. Psychopharmacology (Berlin) 139 (1998) 222-229
37. Panagis G., and Kastellakis A. The effects of ventral tegmental administration of GABA(A), GABA(B), NMDA and AMPA receptor agonists on ventral pallidum self-stimulation. Behav Brain Res 131 (2002) 115-123
38. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, Sydney
39. Perugini M., and Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270 (1994) 690-696
40. Phillips T.J. Behavior genetics of drug sensitization. Crit Rev Neurobiol 11 (1997) 21-33
41. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol Biochem Behav 74 (2002) 187-197
42. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A. Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. J Psychopharmacol 17 (2003) 415-423
43. Rezayof A., Motevasseli T., Rassouli Y., and Zarrindast M.R. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci 80 (2007) 285-292
44. Robertson G.S., and Jian M. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience 64 (1995) 1019-1034
45. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18 (1993) 247-291
46. Robinson T.E., and Berridge K.C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 (2000) 91-117
47. Serrano A., Aguilar M.A., Manzanedo C., Rodriguez-Arias M., and Minarro J. Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 1263-1271
48. Shippenberg T.S., and Bals-Kubik R. Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behav Pharmacol 6 (1995) 99-106
49. Shippenberg T.S., Heidbreder C., and Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. Eur J Pharmacol 299 (1996) 33-39
50. Skoubis P.D., and Maidment N.T. Blockade of ventral pallidal opioid receptors induces a conditioned place aversion and attenuates acquisition of cocaine place preference in the rat. Neuroscience 119 (2003) 241-249
51. Spanagel R. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70 (1995) 37-49
52. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56 (1998) 613-672
53. Tzschentke T.M., and Schmidt W.J. Interaction of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and conditioning behavioral sensitization. Behav Brain Res 84 (1997) 99-107
54. Tzschentke T.M., and Schmidt W.J. Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm. Behav Brain Res 97 (1998) 115-127
55. Yoo J.H., Yang E.M., Lee S.Y., Loh H.H., Ho I.K., and Jang C.G. Differential effects of morphine and cocaine on locomotor activity and sensitization in mu-opioid receptor knockout mice. Neurosci Lett 344 (2003) 37-40
56. Zaborszky L., Alheid G.F., and Heimer L. Mapping of transmitter-specific connections: simultaneous demonstration of anterograde degeneration and changes in the immunostaining pattern induced by lesions. J Neurosci Methods 14 (1985) 255-266
57. Zarrindast M.R., Ahmadi S., Haeri-Rohani A., Rezayof A., Jafari M.R., and Jafari-Sabet M. GABA(A) receptors in the basolateral amygdala are involved in mediating morphine reward. Brain Res 1006 (2004) 49-58
58. Zarrindast M.R., Azami B.N., Rostami P., and Rezayof A. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference. Behav Brain Res 169 (2006) 248-255
59. Zarrindast M.R., Farajzadeh Z., Rostami P., Rezayof A., and Nourjah P. Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats. Behav Brain Res 163 (2005) 100-106
60. Zarrindast M.R., Rezayof A., Sahraei H., Haeri-Rohani A., and Rassouli Y. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res 965 (2003) 212-221
61. Zarrindast M.R., Massoudi R., Sepehri H., and Rezayof A. Involvement of GABA(B) receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats. Physiol Behav 30 (2006) 31-38